JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
RYOAX
Price
$55.26
Change
-$0.20 (-0.36%)
Updated
Feb 21 closing price
Net Assets
94.89M
Ad is loading...

JNGLX vs RYOAX

Header iconJNGLX vs RYOAX Comparison
Open Charts JNGLX vs RYOAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
Rydex Biotechnology H
Price$55.26
Change-$0.20 (-0.36%)
VolumeN/A
Net Assets94.89M
JNGLX vs RYOAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. RYOAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and RYOAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. RYOAX (94.9M). JNGLX pays higher dividends than RYOAX: JNGLX (0.12) vs RYOAX (0.00). JNGLX was incepted earlier than RYOAX: JNGLX (26 years) vs RYOAX (27 years). RYOAX is a more actively managed with annual turnover of: 61.00 vs. JNGLX (34.00). JNGLX (2500) and RYOAX (2500) have matching initial minimum investment requirements. JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. RYOAX (-11.21). JNGLX return over 5 years is better than : 17.54 vs. RYOAX (-25.36).
JNGLXRYOAXJNGLX / RYOAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years27 years-
Gain YTD5.4216.94878%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets5B94.9M5,266%
Annual Yield % from dividends0.120.00-
Returns for 1 year-3.67-11.2133%
Returns for 3 years15.97-4.58-349%
Returns for 5 years17.54-25.36-69%
Returns for 10 years29.25-33.62-87%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P